Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells
Sfoglia tutti i composti in Ricerca sulla guarigione e sul recupero
The peptides development was ultimately discontinued in 2007 after a 24-week Phase III trial failed to demonstrate statistically significant weight loss compared to placebo, though research into its regenerative properties has continued
10.1016/S0376-7388(99)00201-X 126
Dihexa was administered intraperitoneally (i.p.) at 0.5 mg/kg in phosphate buffered saline (PBS) on alternate days, commencing 15 days post-surgery and continuing through day 48, with control animals receiving PBS alone
(8) The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases
US$ 27.31
US$ 26.37
US$ 20.84
